These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 1670966)

  • 1. Neuroleptic malignant syndrome: life-threatening complication of neuroleptic treatment in adolescents with affective disorder.
    Joshi PT; Capozzoli JA; Coyle JT
    Pediatrics; 1991 Feb; 87(2):235-9. PubMed ID: 1670966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuroleptic malignant syndrome. Case reports].
    Berardi D; Troia M; Veronesi L; Ferrari G
    Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome.
    Mooney RP; Hasan MK
    W V Med J; 1990 Mar; 86(3):95-8. PubMed ID: 1969191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroleptic malignant syndrome in users of risperidone].
    Gerritsen AA; de Jonghe-Rouleau AP; Stienstra-Liem LH
    Ned Tijdschr Geneeskd; 2004 Sep; 148(37):1801-4. PubMed ID: 15495506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haloperidol-induced neuroleptic malignant syndrome complicated by hyperosmolar hyperglycemic state.
    Rock W; Elias M; Lev A; Saliba WR
    Am J Emerg Med; 2009 Oct; 27(8):1018.e1-3. PubMed ID: 19857430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome: a case report.
    Fekadu A; Wakwoya A
    Ethiop Med J; 1999 Jul; 37(3):195-8. PubMed ID: 11957317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous administration of lisuride in the treatment of neuroleptic malignant syndrome.
    de Mari M; Lamberti P; Simone F; Iliceto G; Federico F; Ferrari E
    Funct Neurol; 1991; 6(3):285-8. PubMed ID: 1683852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome.
    Addonizio G; Susman VL
    J Clin Psychiatry; 1987 Mar; 48(3):102-5. PubMed ID: 2880837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies of risk factors and preventive care for neuroleptic malignant syndrome].
    Tanii H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Nov; 26(5-6):177-81. PubMed ID: 17240842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature].
    Marelli A; Bodini P; Dizioli P; Chiodelli G; Guarneri M; Boldori L
    Minerva Med; 1996; 87(1-2):45-51. PubMed ID: 8610025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pharmacologic risk factors for neuroleptic malignant syndrome and their association with death.
    Tural U; Onder E
    Psychiatry Clin Neurosci; 2010 Feb; 64(1):79-87. PubMed ID: 20416027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinico-therapeutic observations in the neuroleptic malignant syndrome].
    Grecu G; Grecu-Gaboş M; Nireşteanu A; Grecu-Gaboş I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1989; 34(4):267-76. PubMed ID: 2577227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome: a review of the literature.
    Pearlman CA
    J Clin Psychopharmacol; 1986 Oct; 6(5):257-73. PubMed ID: 2877012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome in Mexico.
    Montoya A; Ocampo M; Torres-Ruiz A
    Can J Clin Pharmacol; 2003; 10(3):111-3. PubMed ID: 14506509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome.
    McHugh TP
    J S C Med Assoc; 1992 Jun; 88(6):303-6. PubMed ID: 1352559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
    Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
    World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polytrauma and malignant neuroleptic syndrome. Case presentation with diagnostic problems].
    Röther J; Jakob J; Bender HJ; Hewer W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1995 Nov; 30(7):455-7. PubMed ID: 8562725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic malignant syndrome: need for early diagnosis and therapy.
    Khan HM; Syed NA; Sheerani M; Khcalani B; Kamal A; Wasay M
    J Ayub Med Coll Abbottabad; 2006; 18(1):17-21. PubMed ID: 16773963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuroleptic malignant syndrome--a case report on diagnosis, differential diagnosis and therapy of a life threatening complication of treatment with neuroleptics].
    Staud L; Pflug B
    Psychiatr Prax; 1992 Jul; 19(4):114-8. PubMed ID: 1354879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.